bims-malgli Biomed News
on Biology of malignant gliomas
Issue of 2026–11–08
seven papers selected by
Oltea Sampetrean, Keio University



  1. Neuro Oncol. 2026 Nov 03. pii: noag277. [Epub ahead of print]
       BACKGROUND: Contemporary risk stratification of isocitrate dehydrogenase (IDH)-mutant lower-grade gliomas relies primarily on molecular characteristics and surgical tumor burden but does not capture dynamic tumor behavior. Our primary objective was to determine whether pretherapeutic tumor growth velocity (TGV) provides independent prognostic information for overall survival (OS) beyond established factors.
    METHODS: This multicenter retrospective study included 569 adults with grade 2-3 IDH-mutant gliomas from three French centers, comprising a development cohort (n = 440) and two external validation cohorts (n = 129). TGV was derived from automated, outcome-blinded volumetric analysis of serial preoperative MRI using mean diameter expansion and log-volume growth. Prognostic value was assessed using multivariable Cox regression, external validation, decision curve analysis, and exploratory random survival forests.
    RESULTS: During a median follow-up of 6.8 years, 73 deaths occurred in the development cohort. Higher TGV was independently associated with shorter overall survival after adjustment for age, sex, grade, 1p/19q status, and postoperative residual tumor volume (HR per 1-mm/year increase, 1.046; 95%CI, 1.011-1.083; P=.011), and was independently replicated externally (HR, 1.077; 95% CI, 1.005-1.153; P=.035). Findings were consistent using log-volume growth and after accounting for CDKN2A/B status. Adding TGV improved prognostic model fit (likelihood-ratio χ²=5.70; P=.017), with greatest incremental value in astrocytomas. Decision curve analysis demonstrated additional clinical utility, while survival forests identified TGV among the strongest survival predictors alongside 1p/19q status and postoperative residual tumor volume.
    CONCLUSIONS: Pretherapeutic TGV independently predicts survival beyond contemporary molecular and surgical factors in IDH-mutant lower-grade gliomas. This accessible MRI-derived biomarker may refine individualized risk stratification, particularly in astrocytoma.
    Keywords:  IDH-mutant glioma; overall survival; risk stratification; tumor growth velocity
    DOI:  https://doi.org/10.1093/neuonc/noag277
  2. Nature. 2026 Nov 04.
      Cancer cells show highly heterogeneous and plastic states in glioblastoma, an incurable brain tumour1-5. However, how these malignant states arise and whether they follow defined cellular trajectories across tumours is poorly understood. Here we generated a deep single-cell and spatial multi-omic atlas of human glioblastoma that pairs transcriptomic, epigenomic and genomic profiling of 12 tumours across many regions. We identify that glioblastoma heterogeneity is driven by spatially patterned transitions of cancer cells from developmental-like states towards those defined by a glial injury response and hypoxia. This cellular trajectory regionalizes tumours into distinct tissue microenvironments and manifests in a molecularly conserved manner across tumours as well as genetically distinct tumour subclones. Consistently, using a new deep-learning framework to map cancer cell states jointly with clones in situ, we show that tumour subclones are finely spatially intermixed through glioblastoma tissue microenvironments. We validate this cellular trajectory by using somatic mutation-based hierarchies in vivo and an experimental patient-derived organoid model ex vivo. Finally, we show that this cancer cell trajectory is intimately linked to myeloid heterogeneity and unfolds across regionalized myeloid signalling environments. Our findings define a stereotyped trajectory of cancer cells in glioblastoma and unify glioblastoma tumour heterogeneity into a tractable cellular and tissue framework.
    DOI:  https://doi.org/10.1038/s41586-026-11234-8
  3. Nat Commun. 2026 11 02. pii: 11245. [Epub ahead of print]17(1):
      Glioblastoma invasion into healthy brain tissue remains a major barrier to effective treatment, but the dynamic single-cell behaviors underlying this process remain difficult to measure across patient models. Here, we introduce GlioTrace, an ex vivo imaging and computational framework for real-time tracking of glioblastoma invasion in patient-derived xenograft brain slices. Combining whole-specimen confocal microscopy with machine learning-based morphology classification and probabilistic modeling of state transitions, GlioTrace reconstructs how tumor cells switch between invasion phenotypes and how these dynamics are shaped by local tissue context and therapy. Across six patient-derived models, GlioTrace reveals that invasion plasticity is patient-specific, spatially organized, and modulated by vascular proximity and microglial interaction. Targeted therapies selectively alter phenotype composition and transition probabilities, whereas standard-of-care treatment enriches a highly motile, transition-connected branching state consistent with a treatment-tolerant invasive phenotype. Thus, GlioTrace makes glioblastoma invasion a measurable dynamic process for comparing patient-specific treatment responses in living brain tissue.
    DOI:  https://doi.org/10.1038/s41467-026-78908-9
  4. Neuro Oncol. 2026 Nov 03. pii: noag271. [Epub ahead of print]
      Diffuse gliomas arise within and become functionally integrated into neural circuits, establishing bidirectional interactions between malignant cells and the surrounding brain. Neuronal activity promotes glioma growth and progression, while glioma cells remodel the excitability, connectivity, and functional organization of the neural circuits they infiltrate. Pathological excitation-inhibition imbalance can impair cortical information processing, while tumor infiltration simultaneously disrupts, preserves, and induces adaptive reorganization of distributed functional networks. Language processing provides a well defined framework for examining these competing effects because language processing depends on distributed cortical and subcortical networks whose organization can be interrogated using neuroimaging, electrophysiology, and direct cortical stimulation. The pattern and severity of glioma-associated language dysfunction reflect the interaction among tumor location, growth kinetics, molecular and histopathological features, white matter involvement, and the capacity for adaptive redistribution of function within ipsilateral and contralateral networks. Slowly growing gliomas can permit substantial functional reorganization, whereas rapidly infiltrating tumors may constrain the time and biological substrate available for effective network adaptation. In this review, we examine reciprocal glioma-neural circuit interactions, with particular emphasis on the mechanisms of glioma-associated neuronal hyperexcitability and the disruption, preservation, and adaptive remodeling of language networks.
    Keywords:  behavior; brain tumor; cancer; cognition; glioma; language; network remodeling
    DOI:  https://doi.org/10.1093/neuonc/noag271